查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1551769

肱骨外上髁炎治療的全球市場

Lateral Epicondylitis Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 283 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，全球肱骨外上髁炎治療市場預計將達到112億美元

肱骨外上髁炎治療的全球市場預計到 2023 年將達到 95 億美元，預計到 2030 年將達到 112 億美元，在 2023-2030 年分析期間複合年成長率為 2.5%。非手術治療是本報告分析的細分市場之一，預計複合年成長率為 2.9%，到分析期結束時將達到 74 億美元。在分析期間，手術治療領域的複合年成長率預計為 1.6%。

美國市場預計26億美元，中國預計複合年成長率5.0%

到2023年，美國肱骨外上髁炎治療市場預計將達到26億美元。中國作為世界第二大經濟體，預計2030年市場規模將達22億美元，2023-2030年分析期間複合年成長率為5.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 0.6% 和 1.8%。在歐洲，德國的複合年成長率預計為 1.2%。

全球肱骨外上髁炎治療市場 - 主要趨勢與促進因素總結

什麼是肱骨外上髁炎？

肱骨外上髁炎，俗稱網球肘，是一種由附著在肘部外上髁上的肌腱發炎和斷裂引起的疼痛性疾病。這種情況通常是由重複性壓力或過度使用前臂肌肉引起的，導致肘部外側疼痛和壓痛。肱骨外上髁炎在運動員中更常見，尤其是網球運動員，但任何從事重複性手腕或手臂運動的人都可能患上外上髁炎，例如油漆工、木工和上班族。這種情況會對您執行日常生活和工作相關任務的能力產生重大影響，因此有效的治療極為重要。如果不及時治療，肱骨外上髁炎可能會導致慢性疼痛和殘疾，這凸顯了早期療育的重要性。了解這種情況的根本原因和機制對於制定有效的治療策略至關重要，這些策略不僅可以緩解症狀，還可以解決問題的根本原因。

目前肱骨外上髁炎的治療方法是什麼？

肱骨外上髁炎的治療包括多種旨在減輕疼痛、促進癒合和恢復功能的方法。保守治療通常是首選，首先透過休息、使用冰敷和非類固醇消炎劑(NSAID) 來控制疼痛和發炎。物理治療在治療中發揮重要作用，重點是前臂肌肉的拉伸和強化練習，以減少受影響肌腱的壓力。事實證明，在緊張狀態下伸展肌肉的離心運動對於促進肌腱癒合特別有效。此外，手腕夾板和反力支架等矯正器具通常用於減少活動期間的壓力。對於保守治療無效的患者，可以考慮更先進的治療，如皮質類固醇注射、富血小板血漿（PRP）治療和衝擊波治療。這些干預措施旨在減少發炎並促進肌腱水平的組織修復。在極少數情況下，如果保守或微創治療不成功，可能需要進行肌腱鬆解或修復等手術治療。治療方法的選擇取決於病情的嚴重程度、患者的偏好以及對初始治療的反應。

肱骨外上髁炎的治療進展如何？

由於醫療技術的創新和持續的研究，肱骨外上髁炎的治療方案不斷發展，為難治性和重症患者帶來了新的希望。最有前景的研究領域之一是再生醫學，尤其是富血小板血漿（PRP）療法。在PRP治療中，患者自身的血小板被濃縮並注射到患處，透過釋放生長因子來促進癒合。這種治療在減輕疼痛和改善功能方面顯示出有希望的結果，特別是在對其他治療方法沒有反應的慢性病例中。另一個創新領域是體外震波療法（ESWT）的開發。 ESWT 使用聲波刺激血流並促進肌腱部位的組織修復。研究表明，ESWT 是治療方法慢性肱骨外上髁炎的有效方法，也是手術的替代治療方法。此外，穿戴式科技的進步透過在復健運動期間提供肌肉活動和張力的即時回饋來增強肱骨外上髁炎的治療。這些創新不僅提高了治療效果，還縮短了復原時間並最大限度地降低了復發風險。

推動肱骨外上髁炎治療市場成長的因素有哪些？

肱骨外上髁炎治療市場的成長是由反映技術進步、患者人口統計變化和醫療保健實踐演變的幾個因素所推動的。主要因素之一是隨著人口老化以及各種職業重複性壓力傷害發生率的增加，包括肱骨外上髁炎的肌肉骨骼疾病的盛行率不斷增加。技術進步，例如 PRP 療法和 ESWT 等微創治療的開發，正在擴大患者的選擇範圍，並促進市場成長。此外，對個人化醫療的日益關注和數位健康工具的整合正在增強肱骨外上髁炎的診斷和治療，使治療變得更加容易和有效。新興市場醫療保健支出的增加和先進治療方案的可用性增加也是推動市場擴張的主要因素。此外，患者和醫療保健提供者意識的提高強調了早期診斷和早期療育，增加了對有效和創新治療的需求。這些因素加上持續的研究和開發，預計將繼續推動肱骨外上髁炎治療市場的成長。

受訪企業舉例（共52家）

  • 3M Company
  • Aksigen Hospital Care
  • Beurer GmbH
  • BioMedical Life Systems, Inc.
  • BTL Industries
  • EMS Physio Ltd.
  • Johari Digital Healthcare Ltd.
  • OMRON Healthcare Co., Ltd.
  • Ossur hf.
  • Ottobock SE & Co. KGaA
  • Seikagaku Corporation
  • Teikoku Pharma USA
  • Zimmer Biomet Holdings, Inc.
  • Zynex, Inc.;

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP26738

Global Lateral Epicondylitis Treatment Market to Reach US$11.2 Billion by 2030

The global market for Lateral Epicondylitis Treatment estimated at US$9.5 Billion in the year 2023, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 2.5% over the analysis period 2023-2030. Non-Surgical Therapies, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Surgical Therapies segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 5.0% CAGR

The Lateral Epicondylitis Treatment market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Lateral Epicondylitis Treatment Market - Key Trends and Drivers Summarized

What Is Lateral Epicondylitis and Why Is Effective Treatment Crucial?

Lateral epicondylitis, commonly known as tennis elbow, is a painful condition resulting from inflammation or microtearing of the tendons that attach to the lateral epicondyle of the elbow. This condition is typically caused by repetitive stress or overuse of the forearm muscles, leading to pain and tenderness on the outer part of the elbow. While it is often associated with athletes, particularly tennis players, lateral epicondylitis can affect anyone who engages in repetitive wrist and arm motions, such as painters, carpenters, or office workers. The condition can significantly impact a person’s ability to perform daily activities and work-related tasks, making effective treatment crucial. Left untreated, lateral epicondylitis can lead to chronic pain and disability, underscoring the importance of early intervention. Understanding the underlying causes and mechanisms of this condition is essential for developing effective treatment strategies that not only alleviate symptoms but also address the root cause of the problem.

What Are the Current Treatment Options for Lateral Epicondylitis?

The treatment of lateral epicondylitis involves a combination of approaches aimed at reducing pain, promoting healing, and restoring function. Conservative treatment is typically the first line of defense, starting with rest, ice application, and nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation. Physical therapy plays a crucial role in treatment, focusing on stretching and strengthening exercises for the forearm muscles to alleviate strain on the affected tendons. Eccentric exercises, where the muscle lengthens under tension, have shown particular efficacy in promoting tendon healing. Additionally, orthotic devices such as wrist splints or counterforce braces are often used to reduce strain during activities. For patients who do not respond to conservative measures, more advanced treatments like corticosteroid injections, platelet-rich plasma (PRP) therapy, or shockwave therapy may be considered. These interventions aim to reduce inflammation or stimulate tissue repair at the tendon level. In rare cases, when conservative and minimally invasive treatments fail, surgical options such as tendon release or repair may be necessary. The choice of treatment depends on the severity of the condition, patient preferences, and the response to initial therapies.

How Are Innovations and Research Advancing the Treatment of Lateral Epicondylitis?

Innovations in medical technology and ongoing research are continuously advancing the treatment options for lateral epicondylitis, offering new hope for patients with persistent or severe cases. One of the most promising areas of research is regenerative medicine, particularly the use of platelet-rich plasma (PRP) therapy. PRP involves injecting a concentrated dose of the patient’s own platelets into the affected area to promote healing through the release of growth factors. This treatment has shown encouraging results in reducing pain and improving function, particularly in chronic cases that have not responded to other therapies. Another area of innovation is the development of extracorporeal shockwave therapy (ESWT), which uses sound waves to stimulate blood flow and promote tissue repair at the tendon site. Research has demonstrated that ESWT can be an effective treatment for chronic lateral epicondylitis, offering an alternative to surgery. Additionally, advancements in wearable technology are enhancing the management of lateral epicondylitis by providing real-time feedback on muscle activity and strain during rehabilitation exercises. These innovations are not only improving the effectiveness of treatment but also reducing recovery times and minimizing the risk of recurrence.

What Factors Are Driving Growth in the Lateral Epicondylitis Treatment Market?

The growth in the lateral epicondylitis treatment market is driven by several factors that reflect technological advancements, changing patient demographics, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of musculoskeletal disorders, including lateral epicondylitis, as a result of aging populations and the rising incidence of repetitive strain injuries in various professions. Technological advancements, such as the development of minimally invasive treatments like PRP therapy and ESWT, have expanded the range of options available to patients and are contributing to the market's growth. Additionally, the growing focus on personalized medicine and the integration of digital health tools are enhancing the diagnosis and management of lateral epicondylitis, making treatments more accessible and effective. The rise in healthcare expenditure and the increasing availability of advanced treatment options in emerging markets are also significant factors fueling market expansion. Furthermore, the emphasis on early diagnosis and intervention, driven by increased awareness among both patients and healthcare providers, is boosting demand for effective and innovative treatments. These factors, combined with ongoing research and development, are expected to continue driving growth in the lateral epicondylitis treatment market.

Select Competitors (Total 52 Featured) -

  • 3M Company
  • Aksigen Hospital Care
  • Beurer GmbH
  • BioMedical Life Systems, Inc.
  • BTL Industries
  • EMS Physio Ltd.
  • Johari Digital Healthcare Ltd.
  • OMRON Healthcare Co., Ltd.
  • Ossur hf.
  • Ottobock SE & Co. KGaA
  • Seikagaku Corporation
  • Teikoku Pharma USA
  • Zimmer Biomet Holdings, Inc.
  • Zynex, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Lateral Epicondylitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sports-Related Injuries Expands Addressable Market Opportunity for Lateral Epicondylitis Treatments
    • Advancements in Non-Surgical Therapies Propel Growth in Conservative Treatment Options for Lateral Epicondylitis
    • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Innovative Lateral Epicondylitis Treatments
    • Integration of Biologic and Regenerative Medicine Throws the Spotlight on Novel Treatment Modalities for Tendon Repair
    • Emergence of Wearable and Assistive Technologies Expands Market Scope for Rehabilitation and Prevention of Lateral Epicondylitis
    • Rising Geriatric Population and Associated Tendon Degeneration Generate Demand for Long-Term Management Solutions
    • Challenges in Treatment Efficacy and Recurrence Rates Present Opportunities for Innovation in Therapeutic Approaches
    • Expansion of Sports Medicine Clinics and Physical Therapy Centers Creates New Opportunities for Lateral Epicondylitis Treatment Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lateral Epicondylitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Non-Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharma & Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION